- Home
- / MediWound
MediWound
Stock Price
$18.2
2024-10-29
Market Capitalization
$196.3 M
2024-10-29
Revenue
$17 M
FY, 2025
MediWound Summary
Company Summary
- Overview
- MediWound is a biotechnology company. It is focused on developing, manufacturing and globally commercializing products that address unmet needs in the fields of burn and chronic wound management. MediWound's aim is to provide healthcare professionals and patients with its burn wound eschar removal agent NexoBrid.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Yavne, IL | view all locations
- Website
- https://www.mediwound.com/
- Cybersecurity rating
Table of Contents
Key People
Stephen T. Wills, Executive Chairman
Vickie R. Driver, Director
Boaz Gur-Lavie, Chief Financial Officer
LocationsView all
3 locations detected
Yavne, Center District HQ
Israel
Ha-Yarkon St 42
Wilmington, DE
United States
1007 N Orange St
Rüsselsheim am Main, HE
Germany
Hans-Sachs-Straße 100
MediWound Financials
Summary Financials
- Revenue (FY, 2025)
- $17.0M
- Gross profit (FY, 2025)
- $4.1M
- Net income (FY, 2025)
- ($23.9M)
- Cash (FY, 2025)
- $4.8M
- EBIT (FY, 2025)
- ($25.3M)
- Enterprise value
- $199.7M